SoxFirst’s NewsCloud Journal

Drugmaker Biovail’s $10 million settlement with the SEC to settle fraud charges makes fascinating reading and tells us that Sarbanes-Oxley did not stop fraud.

Read the full story

This entry was posted on Wednesday, March 26th, 2008 at 9:42 pm and is filed under biovail, fraud. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site. If this a substantial original entry, you can post it to NewsCloud.